CCXI
FINANCIAL SERVICESChemoCentryx Inc
$10.22-0.03 (-0.29%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving CCXI Today?
No stock-specific AI insight has been generated for CCXI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$10.07$11.00
$10.22
Fundamentals
Market Cap$569M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1K
Avg Volume (10D)—
Shares Outstanding41.9M
CCXI News
2 articlesPrice Data
Open$10.22
Previous Close$10.22
Day High$10.22
Day Low$10.22
52 Week High$11.00
52 Week Low$10.07
52-Week Range
$10.07$11.00
$10.22
Fundamentals
Market Cap$569M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1K
Avg Volume (10D)—
Shares Outstanding41.9M
About ChemoCentryx Inc
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Listed February 9, 2026
FINANCIAL SERVICESSHELL COMPANIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICSHELL COMPANIES
CIK—
Composite FIGI—
Share Class FIGI—